Literature DB >> 24965456

Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.

Madelyn R Schmidt1, Lori W McGinnes-Cullen1, Sarah A Kenward1, Kristin N Willems1, Robert T Woodland1, Trudy G Morrison2.   

Abstract

UNLABELLED: Immunization with virus-like particles (VLPs) containing the Newcastle disease virus (NDV) core proteins, NP and M, and two chimera proteins (F/F and H/G) containing the respiratory syncytial virus (RSV) F- and G-protein ectodomains fused to the transmembrane and cytoplasmic domains of NDV F and HN proteins, respectively, stimulated durable RSV-neutralizing antibodies, F-protein-specific long-lived, bone marrow-associated plasma cells (LLPCs), and B cell memory, in striking contrast to RSV infection, which did not (M. R. Schmidt, L. W. McGinnes, S. A. Kenward, K. N. Willems, R. T. Woodland, and T. G. Morrison, J. Virol. 86:11654-11662, 2012). Here we report the characterization of a VLP with an RSV F-protein ectodomain fused to the NDV F-protein heptad repeat 2 (HR2), transmembrane, and cytoplasmic domain sequences, creating a chimera with two tandem HR2 domains, one from the RSV F protein and the other from the NDV F-protein ectodomain (F/HR2F). The F/HR2F chimera protein was efficiently assembled into VLPs along with the H/G chimera protein. This VLP (VLP-H/G+F/HR2F) stimulated anti-F-protein and anti-G-protein IgG, durable RSV-neutralizing antibodies, and anti-RSV F-protein-secreting LLPCs. However, the subtypes of anti-F-protein IgG induced were different from those elicited by VLPs containing the F/F chimera (VLP-H/G+F/F). Most importantly, VLP-H/G+F/HR2F did not induce RSV F-protein-specific B cell memory, as shown by the adoptive transfer of B cells from immunized animals to immunodeficient animals. The VLP did, however, induce B cell memory specific to the RSV G protein. Thus, the form of the F protein has a direct role in inducing anti-F-protein B cell memory. IMPORTANCE: The development of vaccines for respiratory syncytial virus (RSV) is hampered by a lack of a clear understanding of the requirements for eliciting protective as well as durable human immune responses to virus antigens. The results of this study indicate that the form of the RSV F protein has a direct and significant impact on the type of anti-F-protein IgG antibodies induced and the generation of F-protein-specific memory. Identification of the conformation of the RSV F protein that most effectively stimulates not only LLPCs and but also memory B cells will be important in the future development of RSV vaccines.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24965456      PMCID: PMC4136311          DOI: 10.1128/JVI.01250-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Virology: a class act.

Authors:  Theodore S Jardetzky; Robert A Lamb
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

3.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants.

Authors:  Dominique Markine-Goriaynoff; Jean-Paul Coutelier
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 5.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Immunopathogenesis of vaccine-enhanced RSV disease.

Authors:  P J Openshaw; F J Culley; W Olszewska
Journal:  Vaccine       Date:  2001-10-15       Impact factor: 3.641

7.  Respiratory tract viral infections in bone marrow transplant patients.

Authors:  Sonia M Raboni; Meri B Nogueira; Luine R V Tsuchiya; Gislene A Takahashi; Luciane A Pereira; Ricardo Pasquini; Marilda M Siqueira
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

Review 8.  Priming of T follicular helper cells by dendritic cells.

Authors:  André Ballesteros-Tato; Troy D Randall
Journal:  Immunol Cell Biol       Date:  2013-10-22       Impact factor: 5.126

9.  Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts.

Authors:  V Dolganiuc; L McGinnes; E J Luna; T G Morrison
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Activation of virus-specific memory B cells in the absence of T cell help.

Authors:  Barbara J Hebeis; Karin Klenovsek; Peter Rohwer; Uwe Ritter; Andrea Schneider; Michael Mach; Thomas H Winkler
Journal:  J Exp Med       Date:  2004-02-09       Impact factor: 14.307

View more
  11 in total

1.  Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.

Authors:  Lori McGinnes Cullen; Madelyn R Schmidt; Sarah A Kenward; Robert T Woodland; Trudy G Morrison
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

3.  Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.

Authors:  Lori McGinnes Cullen; Madelyn R Schmidt; Trudy G Morrison
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

Review 4.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Meeting report VLPNPV: Session 3: Immune responses.

Authors:  Trudy G Morrison
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.

Authors:  Hye Suk Hwang; Ki-Hye Kim; Youri Lee; Young-Tae Lee; Eun-Ju Ko; SooJin Park; Jong Seok Lee; Byung-Cheol Lee; Young-Man Kwon; Martin L Moore; Sang-Moo Kang
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

7.  Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.

Authors:  Youri Lee; Young-Tae Lee; Eun-Ju Ko; Ki-Hye Kim; Hye Suk Hwang; Soojin Park; Young-Man Kwon; Sang Moo Kang
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

8.  Protein conformation in a vaccine matters.

Authors:  Trudy G Morrison
Journal:  Oncotarget       Date:  2015-09-08

Review 9.  Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.

Authors:  Emma Rey-Jurado; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

10.  Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.

Authors:  Lori McGinnes Cullen; Jorge C G Blanco; Trudy G Morrison
Journal:  J Transl Med       Date:  2015-11-05       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.